Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (176)	1/18/1997 10:45:00 PM
From: Larry Liebman	of 6136

Just so no one should forget...The stock may be running up on the coat-tails of Viracept, HOWEVER, take a look at what their research pipeline has coming up...THYMITAQ is in Phase 11/111 trials with Hoffman-La Roche...The company has entered trials with an anti-cancer MMP inhibitor( take a look at what British Biotech did when they announced their MMP)...Last year, AGPH researchers reported solving structures for protease enzymes for CMV and Hepatitis C...and some time the company may even report on their rhinovirus work( consider the value of inhibiting/preventing the common cold)...)...In addition, there is significant research occurring that is not catching any news...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next